Konica Minolta Unveils New PACS/RIS Platform for Radiologists
The Exa PACS/RIS platform reportedly combines AI-enabled worklist navigation tools with advances in multiplanar functionality and 3D-generated image segmentation.
Offering enhanced imaging capabilities as well as artificial intelligence (AI)-powered tools to promote radiology workflow efficiencies, Konica Minolta has launched the Exa PACS/RIS platform.
Key features of Exa PACS/RIS include the cloud-native NewVue feature, which utilizes AI to enhance efficient worklist navigation, and an automated tool from Clearpath Technologies that streamlines digital sharing of images and records with other providers, according to Konica Minolta.
Artificial-intelligence (AI) powered worklist navigation, improved multiplanar image reconstruction and streamlined sharing of images with other providers are some of the included feature with the newly launched Exa PACS/RIS platform. (Image courtesy of Konica Minolta.)
The company added that Exa PACS/RIS provides bolstered multiplanar reconstruction as well as 3D image reconstruction and segmentation, all of which can be viewed without clicking out of the Exa viewer.
“Confident diagnosis requires more than a single imaging study—it demands the right information, in the right place, at the right time. Our next-generation Exa PACS|RIS delivers powerful clinical and workflow tools, transforming data into actionable insights for smarter decision-making,” noted Matthew Andersen, the executive director of product management for Konica Minolta HCIT.
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
